Literature DB >> 19932758

Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.

Andromachi Scaradavou1, Katherine M Smith, Rebecca Hawke, Allison Schaible, Michelle Abboud, Nancy A Kernan, James W Young, Juliet N Barker.   

Abstract

Double unit cord blood (CB) transplantation (CBT) appears to augment engraftment despite only one unit engrafting in most patients. We hypothesized that superior unit quality, as measured by a higher percentage of viable cells postthaw, would determine the engrafting unit. Therefore, we prospectively analyzed 46 double-unit transplants postthaw using flow cytometry with modified gating that included all dead cells. Using a 75% threshold (mean viability minus 2 SD), 20% of units had low CD34+ cell viability, with viability varying according to the bank of origin. Further, in the 44 patients with single unit engraftment, CD34+ cell viability was higher in engrafting units (P=.0016). Although either unit engrafted if both had high CD34+ viability, units with <75% viability were very unlikely to engraft: in 16 patients who received one high and one low CD34+ viability unit, only 1 of 16 units with viability <75% engrafted (P=.0006). Further, in the single patient without engraftment of either unit, both had CD34+ viability <75%. Finally, poor CD34+ viability correlated with lower colony forming units (CFUs) (P=.02). Our data suggests one mechanism by which double unit CBT can improve engraftment is by increasing the probability of transplanting at least one unit with adequate viability and the potential to engraft. Copyright (c) 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932758      PMCID: PMC4606455          DOI: 10.1016/j.bbmt.2009.11.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  22 in total

1.  Stem cell enumeration by flow cytometry: current concepts and recent developments in CD34+ cell enumeration.

Authors:  M Keeney; D R Sutherland
Journal:  Cytotherapy       Date:  2000       Impact factor: 5.414

2.  The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients.

Authors:  K H Yoo; S H Lee; H-J Kim; K W Sung; H L Jung; E J Cho; H K Park; H A Kim; H H Koo
Journal:  Bone Marrow Transplant       Date:  2007-03-05       Impact factor: 5.483

3.  Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry--time to let go!

Authors:  M Keeney; J W Gratama; I H Chin-Yee; D R Sutherland
Journal:  Cytometry       Date:  1998-12-15

4.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

Authors:  E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

Review 5.  Expanding the role of umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Daniela C Setubal; John E Wagner
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

6.  Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Jeffrey S Miller; John E Wagner
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

7.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

Authors:  P Rubinstein; C Carrier; A Scaradavou; J Kurtzberg; J Adamson; A R Migliaccio; R L Berkowitz; M Cabbad; N L Dobrila; P E Taylor; R E Rosenfield; C E Stevens
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers.

Authors:  D Robert Sutherland; Rakesh Nayyar; Erica Acton; Angeline Giftakis; Sue Dean; Victoria L Mosiman
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

9.  A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

Authors:  Juliet N Barker; Michelle Abboud; Robert D Rice; Rebecca Hawke; Allison Schaible; Glenn Heller; Vincent La Russa; Andromachi Scaradavou
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-25       Impact factor: 5.742

10.  Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.

Authors:  Joanne Kurtzberg; Vinod K Prasad; Shelly L Carter; John E Wagner; Lee Ann Baxter-Lowe; Donna Wall; Neena Kapoor; Eva C Guinan; Stephen A Feig; Elizabeth L Wagner; Nancy A Kernan
Journal:  Blood       Date:  2008-08-21       Impact factor: 22.113

View more
  42 in total

1.  Stem cell therapeutics--reality versus hype and hope.

Authors:  Nicolas H Zech; Karl-Heinz Preisegger; Peter Hollands
Journal:  J Assist Reprod Genet       Date:  2010-12-08       Impact factor: 3.412

2.  Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Authors:  Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-22       Impact factor: 5.742

3.  A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.

Authors:  U Sobol; A Go; S Kliethermes; S Bufalino; T Rodriguez; S Smith; M Parthasarathy; P Stiff
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

4.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Authors:  Stephanie B Tsai; Hongtao Liu; Tsiporah Shore; Yun Fan; Michael Bishop; Melissa M Cushing; Usama Gergis; Lucy Godley; Justin Kline; Richard A Larson; Guadalupe Martinez; Sebastian Mayer; Olatoyosi Odenike; Wendy Stock; Amittha Wickrema; Koen van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-19       Impact factor: 5.742

5.  Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?

Authors:  L Faivre; H Boucher; R Zerbib; T Domet; A Desproges; C Couzin; V Vanneaux; J Larghero; A Cras
Journal:  Bone Marrow Transplant       Date:  2017-07-10       Impact factor: 5.483

6.  Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

Authors:  Duncan Purtill; Katherine Smith; Sean Devlin; Richard Meagher; Joann Tonon; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Cladd E Stevens; Juliet N Barker
Journal:  Blood       Date:  2014-09-02       Impact factor: 22.113

7.  Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.

Authors:  Parastoo B Dahi; Jonathan Barone; Sean M Devlin; Courtney Byam; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Susan H Hsu; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-23       Impact factor: 5.742

8.  CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation.

Authors:  P Ramirez; J E Wagner; T E Defor; C R Eide; J S Miller; D J Weisdorf; C G Brunstein
Journal:  Leukemia       Date:  2012-09-07       Impact factor: 11.528

9.  Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

Authors:  Betül Oran; Kai Cao; Rima M Saliba; Katayoun Rezvani; Marcos de Lima; Sairah Ahmed; Chitra M Hosing; Uday R Popat; Yudith Carmazzi; Partow Kebriaei; Yago Nieto; Gabriela Rondon; Dana Willis; Nina Shah; Simrit Parmar; Amanda Olson; Brandt Moore; David Marin; Rohtesh Mehta; Marcelo Fernández-Viña; Richard E Champlin; Elizabeth J Shpall
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

10.  "No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.

Authors:  Parastoo B Dahi; Doris M Ponce; Sean Devlin; Katherine L Evans; Marissa N Lubin; Anne Marie Gonzales; Joann Tonon; Richard Meagher; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-18       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.